Body salvages cells by altering genes during halt in development About one-quarter of the body's antibodies are produced by immune cells that have had their genetic code revised during a halt in their development, scientists at Rockefeller University and three other institutions have found. The s...

Rockefeller University Professor David D. Ho, M.D., scientific director of the Aaron Diamond AIDS Research Center (ADARC), will receive the Presidential Citizens Medal from President Clinton today in a ceremony at the White House. Ho is one of 28 recipients being recognized for "remarkable servic...

Finding in Cell Culture Should Boost Studies of Virus and Vaccine Design Researchers at Rockefeller University and Washington University School of Medicine in St. Louis have identified mutations in a protein of certain strains of hepatitis C virus (HCV) that allow these strains to replicate more ...

Mode of invasion may provide clues to the early events of other neurological diseases Researchers at Rockefeller University who study the bacterium that causes leprosy say they have identified a component on the microbe’s surface that allows it to specifically select and attack the peripheral ner...

Theresa Gaasterland, Ph.D., a computational biologist at The Rockefeller University, was one of 20 National Science Foundation-supported researchers named by President Clinton as recipients of the fifth annual Presidential Early Career Awards for Scientists and Engineers (PECASE), the highest hon...

Theresa Gaasterland, Ph.D., a computational biologist at The Rockefeller University, was one of 20 National Science Foundation-supported researchers named by President Clinton as recipients of the fifth annual Presidential Early Career Awards for Scientists and Engineers (PECASE), the highest hon...

Second Consecutive Medicine Prize Awarded to a Rockefeller University Scientist For more about his prize-winning research, click Here Paul Greengard, Ph.D., Vincent Astor Professor and head of the Laboratory of Molecular and Cellular Neuroscience at The Rockefeller University, has won the 200...

$4.5 Million Grant from NIH Will Help to Turn Genomic Knowledge into Promising Drug Targets In the wake of the completion of the human genome sequencing project, five New York research institutions have joined together in a collaborative effort to turn that knowledge into promising drug targets. ...

A drug called STI-571, now being tested in clinics to treat a rare form of leukemia, selectively blocks a mutant enzyme that causes the disease without harming its molecular cousins. Reporting in the Sept. 15 issue of Science, a team of researchers from the Howard Hughes Medical Institute at The ...

A team of researchers from The Rockefeller University in New York and the Yale University School of Medicine has identified for the first time a candidate pheromone receptor gene in humans. The findings, reported in the September issue of Nature Genetics, may shed new light on the molecular basis...